Science Current Events | Science News | Brightsurf.com
 

Annals of Internal Medicine publishes new CDC recommendations on hepatitis C screening

August 17, 2012
Without other risk factors, all Americans born between 1945 and 1965 should have a one-time screening for the hepatitis C virus (HCV) according to new recommendations being published early online today in Annals of Internal Medicine, the flagship journal of the American College of Physicians. The Centers for Disease Control and Prevention (CDC) also recommends that all persons identified with HCV should receive a brief alcohol screening and intervention and be referred to appropriate care and treatment services for HCV and related conditions.

Up to 3.9 million people in the United States are infected with HCV, a virus that can cause inflammation and permanent liver damage. The infection is most prevalent among people born from 1945 through 1965, and approximately 50 to 75 percent of those with HCV are unaware that they are infected. This is a problem because HCV progresses slowly, and the risk of serious complications increases as time passes.

The recommendation developers sought to identify testing strategies that would increase the proportion of HCV-infected persons who know their status. In particular, whether a testing strategy based on year of birth would identify persons living with HCV infection who have not been identified by risk-based testing. They conducted a systematic review of evidence published between 1995 and February 2012 to assess the prevalence of HCV and clinical outcomes. They found that the proportion of people born between 1945 and 1965 with HCV antibody was higher than that of the general population. Among that cohort, the recommendation authors found strong evidence that achieving sustained virologic response (SVR) was associated with reduced risk for death and liver cancer.

The CDC recommends that persons identified with HCV have a brief alcohol screening and intervention, as alcohol use has been shown to accelerate the progression of liver disease. The recommendation authors considered evidence from a systematic review of 22 randomized, controlled trials published since 2010 to determine the effects of a brief alcohol intervention versus no intervention on reduction of alcohol use. The research showed that patients who had a brief alcohol reduction intervention reduced their weekly alcohol consumption by an average of 38.42 grams compared with those who had no intervention.

Previously, the CDC recommended antibody screening only of individuals with health or lifestyle indicators suggesting potential infection. These indicators include a history of injecting drugs, having a blood transfusion before 1992, or being a chronic hemodialysis patient. Low case identification may result from the difficulty of implementing risk-based screening given the limited time of primary care visits and unease in discussing behavioral risks.

American College of Physicians


Related Hepatitis C Current Events and Hepatitis C News Articles


Preventing hepatitis C patients from being lost in the health-care system
A new study shows that many patients infected with the hepatitis C virus (HCV) are lost during different stages of health care to manage the disease.

Cocaine, amphetamine users more likely to take their own lives
Stimulants use such as cocaine and amphetamine is associated with a nearly two-fold greater likelihood of suicidal behaviour amongst people who inject drugs.

Hepatitis C ruled out as cause of mental impairment in HIV patients
Advances in treatment for human immunodeficiency virus (HIV) have made it possible for people with HIV to survive much longer.

Geospatial study identifies hotspots in deaths from HIV/AIDS and Hepatitis C in Massachusetts
A new study from epidemiologists at Tufts University School of Medicine helps to identify communities with the greatest public health need in Massachusetts for resources relating to HIV/AIDS and hepatitis C.

Daclatasvir for hepatitis C: added benefit not proven
The drug daclatasvir (trade name Daklinza) has been available since August 2014 for the treatment of adults with chronic hepatitis C (CHC) infection.

Simeprevir-Based Therapy Offers Patients in Developing Countries a Cost-Effective Alternative in Treatment of Hepatitis C
Researchers at Penn Medicine, in collaboration with a multi-center international team, have shown that a protease inhibitor, simeprevir, a once a day pill, along with interferon and ribavirin has proven as effective in treating chronic Hepatitis C virus infection (HCV) as telaprevir with interferon and ribavirin, the standard of care in developing countries.

Researchers from Mainz and Würzburg propose better substances for treating the dengue virus
Researchers from Johannes Gutenberg University Mainz (JGU) and the Julius Maximilian University of Würzburg are proposing potential new active substances for treating the dengue virus. Just like Ebola, dengue fever is also caused by a virus for which there is currently no cure and no vaccine and can be fatal.

The cellular origin of fibrosis
Harvard Stem Cell Institute scientists at Brigham and Women's Hospital have found the cellular origin of the tissue scarring caused by organ damage associated with diabetes, lung disease, high blood pressure, kidney disease, and other conditions.

Life expectancy among patients with chronic hepatitis C virus infection and cirrhosis
Patients with chronic hepatitis C virus infection and advanced fibrosis or cirrhosis who attained sustained virological response (SVR) had survival comparable with that of the general population, whereas patients who did not attain SVR had reduced survival.

IU researcher publishes 'landmark' results for curing hepatitis C in transplant patients
A new treatment regimen for hepatitis C, the most common cause of liver cancer and transplantation, has produced results that will transform treatment protocols for transplant patients, according to research published online today in the New England Journal of Medicine.
More Hepatitis C Current Events and Hepatitis C News Articles

Hepatitis C Treatment One Step at a Time: Inspiration and Practical Tips for Successful Treatment

Hepatitis C Treatment One Step at a Time: Inspiration and Practical Tips for Successful Treatment
by Lucinda Porter RN (Author), Diana Sylvestre MD (foreword) (Foreword)


Hepatitis C Treatment One Step at a Time provides the practical advice and daily inspiration you need to help you successfully complete hepatitis C (HCV) treatment. Deciding to undergo HCV antiviral therapy is one of the bravest and most important steps toward health you'll ever make. As a nurse in the HCV field and a patient who underwent three courses of HCV therapy, Lucinda K. Porter understands how physically and emotionally challenging this experience can be. In Hepatitis C Treatment One Step at a Time, she provides entries for each day of treatment, offering you a daily dose of relief, encouragement, and tips to help you stay on track. From dealing with fatigue and nausea to nosy co-workers and lab results, Porter shows you how to: Prepare mentally, physically, and financially...

Healing Hepatitis and Liver Disease Naturally: Detoxification. Liver gall bladder flush & Cleanse. Cure Hepatitis C and Hepatitis B. Lower blood cholesterol and stop cirrhosis

Healing Hepatitis and Liver Disease Naturally: Detoxification. Liver gall bladder flush & Cleanse. Cure Hepatitis C and Hepatitis B. Lower blood cholesterol and stop cirrhosis
by Peter Oyakhire (Author)


LIVE YOUR LIFE EXPECTANCY WITH CHRONIC LIVER DISEASE.

Studies show that all wellness traditions except western medicine offer detoxification and toxic waste management as a means of natural healing. Using the principles of natural healing and detoxification, Dr. Alexis Carrel, a Nobel Prize winner kept chicken heart alive for 38 years. He believed that cells could live indefinitely and that the secret of life is to feed nutrients to cells and to saturate the cells with Oxygen. If you can't get nutrients into the cells and you don't remove the toxins, the cells will be poisoned by their own waste products. He had found the secret to ageless body and timeless health.

Often overlooked is the pain associated with orthodox management of infective and degenerative liver diseases...

Herbs for Hepatitis C and the Liver (A Storey Medicinal Herb Guide)

Herbs for Hepatitis C and the Liver (A Storey Medicinal Herb Guide)
by Stephen Harrod Buhner (Author)


An insightful overview of the impending Hepatitis C epidemic, its causes, the most recent research, and an in-depth, detailed look at the botanical medicines that show promising results for restoring liver function. Includes formulas for using herbs to strengthen the liver and combat disease.

Hepatitis C Survival Secrets: With Critical Insights Your Doctor Won't Share

Hepatitis C Survival Secrets: With Critical Insights Your Doctor Won't Share
by Ralph Napolitano (Author)


Hepatitis C Survival Secrets can be of tremendous help to anyone with chronic Hepatitis C. The book is based on decades of ongoing research, including countless communications with other Hepatitis C survivors. The goal of the book is to present you with various treatment options that show real evidence for supporting, protecting and improving liver health and function. As a Hepatitis C survivor you need to learn about the many strategies and approaches available to manage your illness. Some people choose to take the conventional medical approach simply because it's covered by health insurance; others choose alternative medications because they believe they will be better off: and still others bury their heads in the sand and do ...

Living With Hepatitis C For Dummies

Living With Hepatitis C For Dummies
by Nina L. Paul (Author), Gina Pollichino (Foreword)


A comprehensive, empathetic guide for anyone suffering from this serious liver disease
Approximately 4 million Americans and 170 million people worldwide suffer from hepatitis C, a viral liver disease that is treatable but not curable. It accounts for more than 40 percent of U.S. liver disease deaths-about 8,000 to 10,000 people annually-and is the most common reason for liver transplantation. This compassionate guide explains how hepatitis C affects the liver and the body and provides solid advice on today's treatment options-from drugs (and their side effects) to transplants and alternative therapies-as well as tips on dealing with the emotional and financial burdens the disease brings with it.
Nina L Paul, PhD (New York, NY) earned her doctorate in infectious disease epidemiology...

Triumph Over Hepatitis C

Triumph Over Hepatitis C
by Lloyd Wright (Author), Annie Waterhouse (Illustrator)


This is the third edition, 2nd printing. This edition of Triumph Over Hepatitis C includes all new information updates. It is important for the reader to understand that HCV has not changed, the way to health has not changed. The only thing that has changed is Big Pharm's quest for your money and their complete disregard for your health.

Hepatitis C A Do-It-Yourself Guide for Health

Hepatitis C A Do-It-Yourself Guide for Health
by Lloyd Wright (Author), David Drum (Editor)


Hepatitis C: A Do-It-Yourself Guide for Health is the newest information I have compiled over the last 17 years. I have listed the supplements I have seen work best in over 200.000 hepatitis c suffers. I have cited numerous studies that show what works and what does not. I have listed the common drugs and vaccines that raise the viral load, ast and alt. You will learn what foods to eat, which are the best supplements for you to take and how to take them. Ansers to your frequently asked questions, blood tests you will need. How to treat the common complications of hepatitis C, Fibrosis, Cirrhosis, Varices, Ascites and Liver Cancer. How you can enhance your body's natural ablity to maintain and heal itself.

A Never Event: Exposing the Largest Outbreak of Hepatitis C in American Healthcare History

A Never Event: Exposing the Largest Outbreak of Hepatitis C in American Healthcare History


CANCER CLINIC CAUSES WORST HEPATITIS OUTBREAK IN US HISTORY

In the small farming community of Fremont, Nebraska, townspeople eagerly welcomed an acclaimed doctor as the first full-time oncologist at their new cancer treatment center—but the fanfare soon turned into a nightmare.

During chemotherapy treatments, 857 patients who were already waging the fights of their lives against cancer, were inexplicably exposed to the deadly, blood-borne hepatitis C virus. At least ninety-nine of them contracted the lethal illness. The horror was unprecedented—this was the largest healthcare-transmitted outbreak of hepatitis C in American history.

A Never Event—a term used to describe a preventable medical tragedy—is a searing story of recklessness,...

Hepatitis C Symptoms, Treatment and Cure: Survivor's true story of 12 week treatment and cure (Hepatitis C Symptoms Treatment and Cure Series)

Hepatitis C Symptoms, Treatment and Cure: Survivor's true story of 12 week treatment and cure (Hepatitis C Symptoms Treatment and Cure Series)


Most people don’t know that there are symptoms of Hepatitis C that go undiagnosed for many years because it rarely causes symptoms in its early stage. Actually, someone who has been carrying Hepatitis C for decades may not have any symptoms until it has caused a significant liver damage. Even then, the symptoms typically appear and disappear.

Living with Hepatitis C, Fifth Edition: A Survivor's Guide

Living with Hepatitis C, Fifth Edition: A Survivor's Guide
by Gregory T. Everson (Author)


The Most Trusted Resource and Reference for Millions of Americans

Living with Hepatitis C was the first book to explain in everyday language the causes of this disease, its major and minor symptoms, and all of the latest treatments available. Researchers have continued to make dramatic strides in helping the millions of Americans who suffer from Hepatitis C since the book's first publication, and each new edition has kept up with the most recent findings.

The latest revised Living With Hepatitis C, Fifth Edition includes cutting-edge information on:

* New treatments including pegylated and consensus interferons
* Living-donor transplants
* Co-infections with Hepatitis B and HIV/AIDS
* Promising new clinical trials of protease and polymerase inhibitors
*...

© 2014 BrightSurf.com